Lapyuen Lam
Chief Tech/Sci/R&D Officer chez ACEPODIA, INC.
Profil
Lapyuen Harry Lam is currently the Chief Technical Officer & EVP-Technical Operations at Acepodia, Inc. He previously held positions as Head-Manufacturing at Humanigen, Inc., Vice President-Manufacturing at Shire Regenerative Medicine, Inc., Vice President-Manufacturing Operations at Minaris Regenerative Medicine LLC, Vice President-Biologics Manufacturing at Sanofi US Services, Inc., Chief Technology Officer at Affinita Biotech, Inc., and Chief Technology Officer & Executive VP at JW (Cayman) Therapeutics Co. Ltd.
Lam received his doctorate from Rensselaer Polytechnic Institute in 1985 and his undergraduate degree from the University of Birmingham in 1981.
Postes actifs de Lapyuen Lam
Sociétés | Poste | Début |
---|---|---|
ACEPODIA, INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
Anciens postes connus de Lapyuen Lam
Sociétés | Poste | Fin |
---|---|---|
Affinita Biotech, Inc. | Chief Tech/Sci/R&D Officer | 01/03/2017 |
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ. | Corporate Officer/Principal | 01/01/2015 |
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Corporate Officer/Principal | 01/01/2014 |
Sanofi US Services, Inc.
Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The private company is based in Bridgewater, NJ. | Corporate Officer/Principal | - |
HUMANIGEN, INC. | Corporate Officer/Principal | - |
Formation de Lapyuen Lam
Rensselaer Polytechnic Institute | Doctorate Degree |
University of Birmingham | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
HUMANIGEN, INC. | Health Technology |
JW (CAYMAN) THERAPEUTICS CO. LTD | Health Technology |
ACEPODIA, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc. BiotechnologyHealth Technology Shire Regenerative Medicine, Inc. develops and commercializes living cell therapies. It manufactures and markets dermagraft, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body's natural healing process. The company was founded in 2004 and is headquartered in Westport, CT. | Health Technology |
Minaris Regenerative Medicine LLC
Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ. | Health Services |
Sanofi US Services, Inc.
Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The private company is based in Bridgewater, NJ. | Health Technology |
Affinita Biotech, Inc. | Commercial Services |